Outlook Therapeutics, Inc. - Se – NASDAQ:OTLKW
Outlook Therapeutics, Inc. - Se stock price today
Outlook Therapeutics, Inc. - Se stock price monthly change
Outlook Therapeutics, Inc. - Se stock price quarterly change
Outlook Therapeutics, Inc. - Se stock price yearly change
Outlook Therapeutics, Inc. - Se key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -0.01 |
EV/Sales | N/A |
EV/EBITDA | 0.64 |
Price/Sales | N/A |
Price/Book | 0.03 |
PEG ratio | N/A |
EPS | -1.66 |
Revenue | N/A |
EBITDA | -90.90M |
Income | -93.28M |
Revenue Q/Q | N/A |
Revenue Y/Y | -100% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOutlook Therapeutics, Inc. - Se stock price history
Outlook Therapeutics, Inc. - Se stock forecast
Outlook Therapeutics, Inc. - Se financial statements
| Mar 2021 | 0 | -13.10M | |
|---|---|---|---|
| Jun 2021 | 0 | -12.19M | |
| Sep 2021 | 0 | -53.16M | |
| Dec 2021 | 0 | -14.81M |
| Payout ratio | 0% |
|---|
| 2018 | 1323021.89% |
|---|---|
| 2019 | |
| 2020 | |
| 2021 | |
| 2023 |
| Mar 2021 | 45111814 | 24.46M | 54.22% |
|---|---|---|---|
| Jun 2021 | 32882068 | 20.13M | 61.23% |
| Sep 2021 | 22811451 | 18.20M | 79.8% |
| Dec 2021 | 78678144 | 29.85M | 37.95% |
| Mar 2021 | -11.74M | 0 | 43.34M |
|---|---|---|---|
| Jun 2021 | -20.19M | 0 | 2.71M |
| Sep 2021 | -8.99M | 0 | 3.77M |
| Dec 2021 | -10.99M | 0 | 66.66M |
Outlook Therapeutics, Inc. - Se other data
| Period | Buy | Sel |
|---|---|---|
| Apr 2021 | 30000 | 0 |
| Nov 2021 | 16000000 | 0 |
| Dec 2021 | 133401 | 0 |
| Feb 2022 | 175132 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | HILZINGER KURT J director | Common Stock | 79,535 | $1.44 | $114,530 | ||
Purchase | HILZINGER KURT J director | Common Stock | 95,597 | $1.49 | $142,440 | ||
Purchase | TRENARY C RUSSELL III director, officer: CEO and Pres.. | Common Stock | 25,000 | $1.39 | $34,750 | ||
Purchase | DAGNON TERRY officer: Chief Op.. | Common Stock | 25,201 | $1.38 | $34,777 | ||
Purchase | DAGNON TERRY officer: Chief Op.. | Common Stock | 10,000 | $1.42 | $14,200 | ||
Purchase | EVANSON JEFF officer: Chief Commercial Officer | Common Stock | 35,200 | $1.34 | $47,168 | ||
Purchase | TRENARY C RUSSELL III director, officer: CEO and Pres.. | Common Stock | 10,000 | $1.4 | $14,000 | ||
Purchase | SUKHTIAN FAISAL GHIATH director | Common Stock | 18,000 | $1.4 | $25,200 | ||
Purchase | HADDADIN YEZAN MUNTHER director | Common Stock | 10,000 | $1.39 | $13,900 | ||
Purchase | SUKHTIAN GHIATH M. director, 10 percent owner | Common Stock | 16,000,000 | $1.25 | $20,000,000 |
-
What's the price of Outlook Therapeutics, Inc. - Se stock today?
One share of Outlook Therapeutics, Inc. - Se stock can currently be purchased for approximately $0.03.
-
When is Outlook Therapeutics, Inc. - Se's next earnings date?
Unfortunately, Outlook Therapeutics, Inc. - Se's (OTLKW) next earnings date is currently unknown.
-
Does Outlook Therapeutics, Inc. - Se pay dividends?
No, Outlook Therapeutics, Inc. - Se does not pay dividends.
-
What is Outlook Therapeutics, Inc. - Se's stock symbol?
Outlook Therapeutics, Inc. - Se is traded on the NASDAQ under the ticker symbol "OTLKW".
-
How do i buy shares of Outlook Therapeutics, Inc. - Se?
Shares of Outlook Therapeutics, Inc. - Se can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Outlook Therapeutics, Inc. - Se went public?
Outlook Therapeutics, Inc. - Se is publicly traded company for more then 9 years since IPO on 20 Jun 2016.